中华腔镜泌尿外科杂志(电子版)
中華腔鏡泌尿外科雜誌(電子版)
중화강경비뇨외과잡지(전자판)
CHINESE JOURNAL OF ENDOUROLOGY(ELECTRONIC VERSION)
2015年
2期
86-90
,共5页
付阳%张古田%熊轶%王彦刚%纪长威%赵晓智%徐林峰%李笑弓%甘卫东%郭宏骞
付暘%張古田%熊軼%王彥剛%紀長威%趙曉智%徐林峰%李笑弓%甘衛東%郭宏鶱
부양%장고전%웅질%왕언강%기장위%조효지%서림봉%리소궁%감위동%곽굉건
嗜铬细胞瘤%腹腔镜%安全性%疗效
嗜鉻細胞瘤%腹腔鏡%安全性%療效
기락세포류%복강경%안전성%료효
Pheochromocytoma%Laparoscope%Safety%Efficacy
目的:探讨腹腔镜手术与开放手术治疗嗜铬细胞瘤的安全性和疗效。方法回顾性分析南京鼓楼医院2010年10月至2014年3月间住院确诊为嗜铬细胞瘤的58例患者临床资料,左侧肾上腺嗜铬细胞瘤22例,右侧26例,双侧2例,异位嗜铬细胞瘤8例。按手术方式分为腹腔镜组和开放组,比较两组术中、术后及预后相关指标。结果两组58例手术均获得成功,术后病理均确诊为嗜铬细胞瘤。腹腔镜组和开放组的手术时间分别是(162±56)min和(213±44)min(t=3.30,P=0.001);术中出血量分别是(158±402)ml和(1081±825)ml(z=-3.44,P=0.000);术后住院时间分别是(9±2)d和(12±2) d(t=4.14,P=0.000);肿瘤估算体积分别是(34±53)cm3和(197±397)cm3(z=-3.46,P=0.000);腹腔镜组(41例)的术中输血、术中高血压、术后并发症的例数分别是7例、18例、1例,开放组(17例)则分别为12例、8例、4例,除术中高血压差异不明显外,两组的术中输血、术后并发症的例数均差异显著。两组58例均获随访,随访时间为5~42个月,两组疗效满意,均未出现肿瘤复发和转移。结论腹腔镜手术治疗嗜铬细胞瘤安全、有效;同样适用于异位嗜铬细胞瘤的手术治疗。
目的:探討腹腔鏡手術與開放手術治療嗜鉻細胞瘤的安全性和療效。方法迴顧性分析南京鼓樓醫院2010年10月至2014年3月間住院確診為嗜鉻細胞瘤的58例患者臨床資料,左側腎上腺嗜鉻細胞瘤22例,右側26例,雙側2例,異位嗜鉻細胞瘤8例。按手術方式分為腹腔鏡組和開放組,比較兩組術中、術後及預後相關指標。結果兩組58例手術均穫得成功,術後病理均確診為嗜鉻細胞瘤。腹腔鏡組和開放組的手術時間分彆是(162±56)min和(213±44)min(t=3.30,P=0.001);術中齣血量分彆是(158±402)ml和(1081±825)ml(z=-3.44,P=0.000);術後住院時間分彆是(9±2)d和(12±2) d(t=4.14,P=0.000);腫瘤估算體積分彆是(34±53)cm3和(197±397)cm3(z=-3.46,P=0.000);腹腔鏡組(41例)的術中輸血、術中高血壓、術後併髮癥的例數分彆是7例、18例、1例,開放組(17例)則分彆為12例、8例、4例,除術中高血壓差異不明顯外,兩組的術中輸血、術後併髮癥的例數均差異顯著。兩組58例均穫隨訪,隨訪時間為5~42箇月,兩組療效滿意,均未齣現腫瘤複髮和轉移。結論腹腔鏡手術治療嗜鉻細胞瘤安全、有效;同樣適用于異位嗜鉻細胞瘤的手術治療。
목적:탐토복강경수술여개방수술치료기락세포류적안전성화료효。방법회고성분석남경고루의원2010년10월지2014년3월간주원학진위기락세포류적58례환자림상자료,좌측신상선기락세포류22례,우측26례,쌍측2례,이위기락세포류8례。안수술방식분위복강경조화개방조,비교량조술중、술후급예후상관지표。결과량조58례수술균획득성공,술후병리균학진위기락세포류。복강경조화개방조적수술시간분별시(162±56)min화(213±44)min(t=3.30,P=0.001);술중출혈량분별시(158±402)ml화(1081±825)ml(z=-3.44,P=0.000);술후주원시간분별시(9±2)d화(12±2) d(t=4.14,P=0.000);종류고산체적분별시(34±53)cm3화(197±397)cm3(z=-3.46,P=0.000);복강경조(41례)적술중수혈、술중고혈압、술후병발증적례수분별시7례、18례、1례,개방조(17례)칙분별위12례、8례、4례,제술중고혈압차이불명현외,량조적술중수혈、술후병발증적례수균차이현저。량조58례균획수방,수방시간위5~42개월,량조료효만의,균미출현종류복발화전이。결론복강경수술치료기락세포류안전、유효;동양괄용우이위기락세포류적수술치료。
Objective We conducted a retrospective cohort study to determine whether laparoscopic resection of pheochromocytoma is a safe and effective therapy for the management of pheochromocytoma, compared with open resection. Methods We collected pertinent data on 58 patients underwent pheochromocytoma resections. Perioperative outcomes of 41 laparoscopic resections of pheochromocytoma were compared with 17 open resections. Results Time of postoperative stay was shorter in the laparoscopic group [(9±2) d vs (12±2) d, P<0.05)], and tumour size was smaller [(34±53) cm3 vs (197±397) cm3, P<0.05)]. The operation time was also shorter in laparoscopic group [(162±56) min vs (213±44) min, P<0.05)], the blood loss was less [(158±402) ml vs (1081±825) ml, P<0.05)]. There were no statistically significant differences in intraoperative hypertensive episodes, the need for antihypertensive and vasopressin agents between the two group. The number of blood transfusion and postoperative complications in laparoscopic group were 7 case and 1 case while there were 12 case and 4 case in open group. During the follow-up of 5 to 47 months, there were no tumor recurrences or metastasis. There were no perioperative mortalities in this series. Conclusions The laparoscopic removal of pheochromocytoma is safe and effective. And also can be used for ectopic pheochromocytoma.